Try Alerts Free   |   Login
Health Care › Biological Products (No Diagnostic Substances)

Gilead Sciences (GILD) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 45 quarters since 2010. Compare with GILD stock chart to see long term trends.

GILD stock compared to

GILD Income Statement

Revenue, Net:6423000000
Revenue Per Share:5.11
Cost of Goods & Services Sold:1361000000
Selling, General & Admin Expense:1055000000
Research & Development Expense:1055000000
Total Operating Expenses:3533000000
Operating Income:2890000000
Income Taxes:542000000
Net Income:1729000000
Earnings Per Share, Basic:1.38
Shares Outstanding, Basic Avg:1256000000

GILD Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:-975000000
Net Cash from Operations:2610000000
Repurchases/Buybacks Common Stock:309000000
Cash Dividends Paid:917000000
Net Cash from Financing Activities:-2477000000
Property, Plant & Equipment Purchases:165000000
Purchases of Businesses, Net of Cash:1255000000
Net Cash from Investing Activities:-2042000000
Net Change in Cash & Equivalents:-1932000000

GILD Balance Sheet

Cash and Cash Equivalents:4065000000
Short-Term Investments:1601000000
Accounts Receivable, Net:3925000000
Inventories:1779000000
Total Current Assets:13278000000
Property, Plant & Equipment, Net:4990000000
Total Assets:67492000000
Accounts Payable:570000000
Current Portion of Long-Term Debt:2259000000
Total Short-Term Liabilities:9705000000
Long Term Debt, Non-Current Portion:27907000000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Blackrock Inc.
117,783,804 sh
1,949,534 sh
2%
$7,442,757
-$1,469,532
Vanguard Group Inc
102,722,460 sh
-2,090,879 sh
-2%
$6,491,033
-$1,573,306
Northern Trust Corp
15,853,066 sh
-228,140 sh
-1%
$1,001,755
-$235,534
Dodge & Cox
12,607,853 sh
15,341 sh
0%
$796,690
-$172,178
Legal & General Group Plc
9,104,511 sh
-44,489 sh
0%
$575,311
-$128,524
UBS Asset Management Americas Inc
8,604,194 sh
349,009 sh
4%
$543,699,018
-$91,454,917
Price T Rowe Associates Inc /Md/
8,082,091 sh
-764,496 sh
-9%
$510,707
-$169,949
FMR LLC
7,710,225 sh
-4,892,313 sh
-39%
$487,209
-$482,431
Renaissance Technologies LLC
7,651,879 sh
-1,249,368 sh
-14%
$483,522
-$201,340
Bank Of America Corp /De/
7,361,010 sh
6,703,010 sh
1019%
$465,142
$414,515
Royal Bank Of Canada
6,675,611 sh
6,505,611 sh
3827%
$421,831
$408,751
Charles Schwab Investment Management Inc
6,515,559 sh
-390,755 sh
-6%
$411,719
-$119,653
Morgan Stanley
6,017,516 sh
189,169 sh
3%
$380,248
-$68,185
Ameriprise Financial Inc
4,636,347 sh
141,898 sh
3%
$291,048
-$55,070
Amundi Pioneer Asset Management Inc
4,299,151 sh
590,331 sh
16%
$271,600
-$13,772
Invesco Ltd.
4,260,596 sh
-2,128,881 sh
-33%
$269,228
-$222,377
Credit Suisse Ag/
4,151,056 sh
3,931,056 sh
1787%
$262,306
$245,379
Parnassus Investments /Ca
3,525,824 sh
3,098 sh
0%
$222,797
-$48,242
Prudential Financial Inc
3,346,990 sh
1,166,443 sh
53%
$211,496
$43,725
Goldman Sachs Group Inc
3,295,587 sh
3,114,887 sh
1724%
$208,249
$194,346

Data imported from Gilead Sciences Inc SEC filings. Check original filings before making any investment decision.